Fall-risk monitoring

Falls don't happen suddenly. Your gait warns you first.

Gait declines for months before a fall — but it's measured once a year, in clinic. A shoe is worn every day. Put the measurement where the walking already happens, and you catch the decline weeks ahead, while there's still time to act.

1 in 4adults 65+ fall each year (CDC)
$50–80Bannual US cost of older-adult falls
$100Bprojected by 2030
The prototype

Daily monitor vs. the annual snapshot

90 days of one person's gait speed. The shoe reads it every day; the clinic sees it once. Press play and watch which one catches the fall coming.

Daily (shoe) Annual check (clinic) Fall-risk line (1.0 m/s)
Annual snapshot

Last clinic check: 1.14 m/s — "normal." Next visit in ~8 months. The decline happens in the gap. The fall arrives before the calendar does.

Daily monitor

Crosses the 1.0 m/s fall-risk line on day —. Alert fires — days before the fall — time to intervene: PT, balance work, the offloading shoe, a caregiver check.

Illustrative trajectory for demonstration. Thresholds reflect published gait-speed fall-risk bands (<1.0 m/s elevated; <0.6 m/s high). Decline-before-fall pattern per CDC / gait-speed literature.
Why the shoe

The shoe is the daily sensor

Adherence is the whole game in monitoring — and a senior already carries a phone and puts their shoes on every morning. The measurement rides along, no new habit required. Four ways to capture it:

The intervention

Flagging the decline is half. The intervention has a dose.

An alert that routes into an under-dosed program does not reduce falls — and the outcome the billing depends on never arrives. These are the published thresholds the intervention has to clear. The same sensor that flags the decline can verify they were met.

3×/week
Minimum frequency. Twice weekly shows meaningfully smaller effect sizes in meta‑analysis. Three is the threshold most associated with actual fall reduction.
≥50 hrs
Cumulative exposure. Total dose predicts fall reduction better than any single session length. Programs under this threshold show a weaker effect regardless of how they’re structured.
Calibrated
“Somewhat difficult, not mastered.” Reduced base of support, minimal hand support, controlled weight shift. Challenge level correlates with effect size more than exercise type does.
It fades
Benefit attenuates after the program stops. Discharge has to include maintenance — and continuous measurement is the only thing that catches the drop-off when it happens.
The reference program. Otago — strength and balance 3×/week, walking 2×/week, progressed by a PT at weeks 1, 4, 8, then monthly — produced roughly a 35% reduction in falls and fall-related injuries, with best evidence in adults 80+ or with a fall history. A program at 2×/week, well under 50 cumulative hours, at a comfortable difficulty is not a smaller version of that. It is a different intervention with a weaker effect.
Sherrington et al. 2017/2019 dose-response and Cochrane falls prevention review; Robertson et al. 2001; Campbell & Robertson 2003 (Otago). Thresholds are population-level evidence, not a prescription — dosing belongs to the treating clinician.

This is what closes the loop. A platform that measures the decline and the dose can show the intervention was actually delivered at the level the evidence requires — which is the difference between a monitoring service and a monitoring service that moves the outcome it bills for.

The business

A reimbursable monitoring service, not a gadget

The shoe partner provides daily wear. MotionSole provides the measurement, the risk-trajectory engine, and the billing. The intervention and the patient relationship route into the network we already run.

1
Measure daily

Camera or sensor insole captures gait every day — the trajectory, not a snapshot.

2
Flag the decline

The engine watches the slope; an alert fires when risk rises — weeks before a fall.

3
Intervene

Route to PT, balance training, the offloading shoe, or a co-op.care caregiver. Patient front door: fallrisks.com.

4
Bill it

Continuous monitoring qualifies under CMS RPM/RTM (98975–98981), under the clinician's own NPI via SurgeonValue. Falls also move Medicare Advantage Star ratings.

Recurring revenue, per monitored patient
~$100–160/patient / month
CMS RPM/RTM, billed monthly while monitored.
1,000 monitored seniors× ~$120/mo
Annual recurring≈ $1.4M
One serious fall avoidedsaves ~$30–50K
Illustrative. Rates vary by locality/year; RPM and RTM are mutually exclusive per patient/period.
Educational prototype, not a medical device. The trajectory shown is illustrative; fall-risk thresholds reflect published gait-speed bands and the CDC STEADI framework. Clinical decisions belong to a qualified professional. MotionSole is an intelligence and billing layer; daily-wear hardware is provided by partners.
See your gait, live → Fall-risk engine of MotionSole — the 6th vital sign.